Cargando…
Predictive approaches to heterogeneous treatment effects: a scoping review
BACKGROUND: Recent evidence suggests that there is often substantial variation in the benefits and harms across a trial population. We aimed to identify regression modeling approaches that assess heterogeneity of treatment effect within a randomized clinical trial. METHODS: We performed a literature...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585220/ https://www.ncbi.nlm.nih.gov/pubmed/33096986 http://dx.doi.org/10.1186/s12874-020-01145-1 |
_version_ | 1783599742226268160 |
---|---|
author | Rekkas, Alexandros Paulus, Jessica K. Raman, Gowri Wong, John B. Steyerberg, Ewout W. Rijnbeek, Peter R. Kent, David M. van Klaveren, David |
author_facet | Rekkas, Alexandros Paulus, Jessica K. Raman, Gowri Wong, John B. Steyerberg, Ewout W. Rijnbeek, Peter R. Kent, David M. van Klaveren, David |
author_sort | Rekkas, Alexandros |
collection | PubMed |
description | BACKGROUND: Recent evidence suggests that there is often substantial variation in the benefits and harms across a trial population. We aimed to identify regression modeling approaches that assess heterogeneity of treatment effect within a randomized clinical trial. METHODS: We performed a literature review using a broad search strategy, complemented by suggestions of a technical expert panel. RESULTS: The approaches are classified into 3 categories: 1) Risk-based methods (11 papers) use only prognostic factors to define patient subgroups, relying on the mathematical dependency of the absolute risk difference on baseline risk; 2) Treatment effect modeling methods (9 papers) use both prognostic factors and treatment effect modifiers to explore characteristics that interact with the effects of therapy on a relative scale. These methods couple data-driven subgroup identification with approaches to prevent overfitting, such as penalization or use of separate data sets for subgroup identification and effect estimation. 3) Optimal treatment regime methods (12 papers) focus primarily on treatment effect modifiers to classify the trial population into those who benefit from treatment and those who do not. Finally, we also identified papers which describe model evaluation methods (4 papers). CONCLUSIONS: Three classes of approaches were identified to assess heterogeneity of treatment effect. Methodological research, including both simulations and empirical evaluations, is required to compare the available methods in different settings and to derive well-informed guidance for their application in RCT analysis. |
format | Online Article Text |
id | pubmed-7585220 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-75852202020-10-26 Predictive approaches to heterogeneous treatment effects: a scoping review Rekkas, Alexandros Paulus, Jessica K. Raman, Gowri Wong, John B. Steyerberg, Ewout W. Rijnbeek, Peter R. Kent, David M. van Klaveren, David BMC Med Res Methodol Research Article BACKGROUND: Recent evidence suggests that there is often substantial variation in the benefits and harms across a trial population. We aimed to identify regression modeling approaches that assess heterogeneity of treatment effect within a randomized clinical trial. METHODS: We performed a literature review using a broad search strategy, complemented by suggestions of a technical expert panel. RESULTS: The approaches are classified into 3 categories: 1) Risk-based methods (11 papers) use only prognostic factors to define patient subgroups, relying on the mathematical dependency of the absolute risk difference on baseline risk; 2) Treatment effect modeling methods (9 papers) use both prognostic factors and treatment effect modifiers to explore characteristics that interact with the effects of therapy on a relative scale. These methods couple data-driven subgroup identification with approaches to prevent overfitting, such as penalization or use of separate data sets for subgroup identification and effect estimation. 3) Optimal treatment regime methods (12 papers) focus primarily on treatment effect modifiers to classify the trial population into those who benefit from treatment and those who do not. Finally, we also identified papers which describe model evaluation methods (4 papers). CONCLUSIONS: Three classes of approaches were identified to assess heterogeneity of treatment effect. Methodological research, including both simulations and empirical evaluations, is required to compare the available methods in different settings and to derive well-informed guidance for their application in RCT analysis. BioMed Central 2020-10-23 /pmc/articles/PMC7585220/ /pubmed/33096986 http://dx.doi.org/10.1186/s12874-020-01145-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Rekkas, Alexandros Paulus, Jessica K. Raman, Gowri Wong, John B. Steyerberg, Ewout W. Rijnbeek, Peter R. Kent, David M. van Klaveren, David Predictive approaches to heterogeneous treatment effects: a scoping review |
title | Predictive approaches to heterogeneous treatment effects: a scoping review |
title_full | Predictive approaches to heterogeneous treatment effects: a scoping review |
title_fullStr | Predictive approaches to heterogeneous treatment effects: a scoping review |
title_full_unstemmed | Predictive approaches to heterogeneous treatment effects: a scoping review |
title_short | Predictive approaches to heterogeneous treatment effects: a scoping review |
title_sort | predictive approaches to heterogeneous treatment effects: a scoping review |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585220/ https://www.ncbi.nlm.nih.gov/pubmed/33096986 http://dx.doi.org/10.1186/s12874-020-01145-1 |
work_keys_str_mv | AT rekkasalexandros predictiveapproachestoheterogeneoustreatmenteffectsascopingreview AT paulusjessicak predictiveapproachestoheterogeneoustreatmenteffectsascopingreview AT ramangowri predictiveapproachestoheterogeneoustreatmenteffectsascopingreview AT wongjohnb predictiveapproachestoheterogeneoustreatmenteffectsascopingreview AT steyerbergewoutw predictiveapproachestoheterogeneoustreatmenteffectsascopingreview AT rijnbeekpeterr predictiveapproachestoheterogeneoustreatmenteffectsascopingreview AT kentdavidm predictiveapproachestoheterogeneoustreatmenteffectsascopingreview AT vanklaverendavid predictiveapproachestoheterogeneoustreatmenteffectsascopingreview |